United Kingdom's Boots Dentalcare chooses CAESY
Dentistry Online, Inc., home to CAESY Education Systems, announced that Boots, the largest pharmacy in the United Kingdom, has chosen CAESY, CAESY Clubhouse, and The Smile Channel to provide patient education in its dental clinics.
"Dentists all over the world use CAESY to increase their patients' dental IQ. This not only elevates case acceptance, but maximizes staff operatory time, eases patient anxiety, and enhances the dentists' credibility as well," said Bob Rondeau, DMD, president of Dentistry Online, Inc. "CAESY is used by nearly 15,000 dentists worldwide. Dental practices from Brazil to Japan rely on CAESY to provide patients with the information they need to accept the treatment that's right for them. Now, with Boots Dentalcare choosing CAESY, The Smile Channel, and CAESY Clubhouse for its upscale practices throughout the U.K., CAESY's global reach has been taken to the next level."
Deproco now sole owner of Septodont, Inc.
Deproco, Inc., has announced the signing of an agreement that would make it the sole owner of Septodont, Inc., a manufacturer and distributor of dental anesthetic and other professional dental products. Septodont, Inc., had previously been held jointly by Deproco, Inc., a privately owned U.S. company, and Henry Schein, Inc. Terms of the sale were not disclosed.
Septodont, Inc., the exclusive North American distributor for Septodont products, is also the owner of two additional dental manufacturing groups - Novocol Pharmaceutical of Canada, Inc., and Confi-Dental Products. Novocol, located in Cambridge, Ontario, Canada, is the leading manufacturer of dental anesthetics in North America. The company produces a variety of dental anesthetic formulations under its own brand names and for private-label customers in the U.S., Canada, and other international markets. Confi-Dental, located in Louisville, Colo., is the largest U.S. contract manufacturer specializing in dental composites and cements.
"This new company represents the largest manufacturer solely dedicated to the production of dental anesthetics," said Kent Chiu, president of Septodont, Inc. "We are looking forward to growing our business through the introduction of new anesthetic formulations and technology."
California dental unit to use Apteryx's XVa3
XVa3, a product of Apteryx, Inc., a software dvelopment company specializing in software applications for the dental market, has been chosen by the state of California's Office of Medical Dental Services (OMDS) and Delta Dental Plan of California to acquire and analyze dental X-rays and other images to assure compliance with Medicaid guidelines.
"We have developed XVa3 as both a single-user, mobile application for use on laptop computers and as a multiuser large network application," said Kevin Crucs, president and founder of Apteryx, Inc. "In this installation, OMDS and Delta Dental will utilize XVa3 in both formats, with laptops for their field representatives who are acquiring X-rays in the field and for representatives in their respective offices who review remotely acquired images."